• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

    0.2529 +0.0017 (+0.68%)
    Streaming Delayed Price Updated: 9:56 AM EDT, Sep 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 80,512
    Open 0.2515
    Bid (Size) 0.2525 (400)
    Ask (Size) 0.2600 (1,000)
    Prev. Close 0.2512
    Today's Range 0.2515 - 0.2578
    52wk Range 0.2425 - 3.050
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    From Medicus Pharma Ltd
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
    Dr. Mehmud’s appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev 
    From Medicus Pharma Ltd
    Via GlobeNewswire

    Performance

    YTD
    -84.2%
    -84.2%
    1 Month
    -16.0%
    -16.0%
    3 Month
    -24.3%
    -24.3%
    6 Month
    -82.8%
    -82.8%
    1 Year
    -87.8%
    -87.8%

    More News

    Read More
    News headline image
    Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
    From New to The Street
    Via ACCESS Newswire
    Top movers in Friday's after hours session ↗
    Via Chartmill
    News headline image
    Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
    From New to The Street
    Via ACCESS Newswire
    News headline image
    Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
    From New to The Street
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Graphene Manufacturing (OTCQX: GMGMF) (TSXV: GMG) Showcases Next-Generation Energy Storage and Graphene Innovation on Bloomberg TV – See INHD, SUNE, TDIC, DOSE Inside
    Via AB Newswire
    Topics Artificial Intelligence Energy
    News headline image
    Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Announces $22 Million Non-Dilutive Financing
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    News headline image
    New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, and Global Workforce Technology
    Via ACCESS Newswire
    News headline image
    New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From Medicus Pharma Ltd
    Via GlobeNewswire

    Frequently Asked Questions

    Is Medicus Pharma Ltd. - Common Stock publicly traded?
    Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
    What exchange does Medicus Pharma Ltd. - Common Stock trade on?
    Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
    The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
    What is the current price of Medicus Pharma Ltd. - Common Stock?
    The current price of Medicus Pharma Ltd. - Common Stock is 0.2529
    When was Medicus Pharma Ltd. - Common Stock last traded?
    The last trade of Medicus Pharma Ltd. - Common Stock was at 09/02/26 09:56 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.